Editorial Board ::: Current Diabetes Reviews

ISSN: 1875-6417 (Online)
ISSN: 1573-3998 (Print)


Volume 13, 6 Issues, 2017


Download PDF Flyer




Current Diabetes Reviews

This journal supports open access

Aims & ScopeAbstracted/Indexed in


Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:
Norman E. Cameron
University of Aberdeen
Aberdeen, Scotland
UK


View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Editorial Board

Editor-in-Chief:

Norman E. Cameron (Biography
Norman E. Cameron

Dr. Cameron graduated from East Anglia University (Norwich, UK) and obtained a doctorate (D.Phil.) from Sussex University (Brighton, UK). After completing postdoctoral positions in the UK and internationally, Dr. Cameron was awarded a Personal Chair in Vascular Neurobiology at the University of Aberdeen (Aberdeen, Scotland, UK). Currently he is Emeritus Professor of Physiology at Aberdeen. Dr. Cameron has published more than 150 original papers, reviews and book chapters. He is currently the Editor-in-Chief of this journal (Current Diabetes Reviews), published by Bentham Science Publishers.

)

University of Aberdeen
Aberdeen, Scotland
UK



Associate Editors:

J.F. Arevalo (Biography
J.F. Arevalo

J. Fernando Arevalo, a holder of M.D. and FACS degrees, has been recognized as one of the leading ophthalmologists in South America and in 2001 founded the Arevalo-Coutinho Foundation for Research in Ophthalmology. In 2011, Dr. Arevalo was invited by Johns Hopkins University (JHU) in Baltimore to work as a Professor of Ophthalmology and the Chief of the Retina Division of the King Khaled Eye Hospital (KKESH) in Riyadh, Saudi Arabia for a four-year tenure (July 2011-15), followed by an appointment at the Wilmer Eye Institute as the Edmund F. and Virginia B. Ball Professor of Ophthalmology in the Retina Division, and an appointment as chief of ophthalmology at Johns Hopkins Bayview Medical Center in 2015. As a clinical scientist, Dr. Arevalo has more than 800 scientific publications (more than 240 on MEDLINE), 12 books, more than 700 scientific paper presentations, and more than 1000 invited lecture presentations in North-America, South-America, Central-America, Europe, Africa, and Asia that have led to international recognition and awards.

)

Johns Hopkins University School of Medicine
Baltimore, MD
USA

G. Umpierrez (Biography
G. Umpierrez

Dr. Umpierrez is professor of medicine in the division of endocrinology and clinical director of the Diabetes and Metabolism Center at Emory University School of Medicine, and director of the diabetes and endocrinology section and clinical research unit at Grady Memorial Hospital, Atlanta, Georgia. His research interests include mechanisms for beta-cell dysfunction in minority populations and the management of inpatient hyperglycemia. He is a national and international leader in the field of hospital management of diabetes and has published several landmark papers and guidelines in the field of inpatient diabetes. He has published more than 280 scientific manuscripts and textbook chapters, and has presented over 300 abstracts at national and international scientific meetings.

)

Emory University School of Medicine
Atlanta, GA
USA

J. Evans (Biography
J. Evans

Joseph L. Evans, Ph.D., is Executive Manager, Research and Development, Stratum Nutrition (Saint Charles, MO, USA), and a Novus International Science Fellow. Dr. Evans holds a Ph.D. in Biochemistry from Drexel University, and received post-doctoral training in physiology and pharmacology at Dartmouth Medical School and the Panum Institute. Dr. Evans’ translational research experience extends from mechanistic research through randomized, controlled, clinical trials, and has successfully focused on the discovery and commercialization of pharmacological and nutritional interventions for the metabolic and cardiovascular diseases. Dr. Evans has published approximately 80 peer-reviewed scientific papers, review articles, book chapters, abstracts, and US patents.

)

Stratum Nutrition
Saint Louis, MO
USA

T. Yada
Jichi Medical University, School of Medicine
Shimotsuke
Japan

R.P. Hoffman (Biography
R.P. Hoffman

Dr. Hoffman obtained his medical degree (M.D.) from The Ohio State University College of Medicine. He did his pediatric residency at the Akron Children’s Hospital and his pediatric endocrinology fellowship at Children’s Hospital of Pittsburgh. He is currently a Professor of Pediatrics and Program Director for the Pediatric Endocrinology Fellowship at Nationwide Children’s Hospital and The Ohio State University. His research interests are type 1 diabetes, hypoglycemia and the cardiovascular endocrinology.

)

Nationwide Children's Hospital
Columbus, OH
USA


Regional Editors:

Region: North America
F. B. Folli
University of Texas Health Science Center
San Antonio, TX
USA
L. Qi (Biography
L. Qi

Dr. Qi obtained a medical degree in China and PhD at Tufts University in the United States. He is now HCA Regents Distinguished Chair and Professor in Tulane University and Adjunct Professor at Harvard T.H Chan School of Public Health. He has published more than 210 scientific publications and edited a textbook.

)

Harvard School of Public Health
Boston, MA
USA
Region: Europe
M. Hernaez-Ortega (Biography
M. Hernaez-Ortega

Dr. Hernaez-Ortega obtained a doctorate (Ph.D.) in Ophthalmology from the University of Valladolid (Spain), and completed her training in vitreoretinal surgery at the Bascom Palmer Eye Institute (Miami, USA) and the Jules Stein Eye Institute (Los Angeles, USA). Dr. Hernaez-Ortega is a member of the Spanish Retina and Vitreous Society (SERV) and the European Society of Retina Specialists (EURETINA). She has nearly 20 years of experience in the research and medical-surgical treatment of diabetic eye complications. Dr. Hernaez-Ortega has authored and co-authored more than 30 scientific manuscripts and book chapters.

)

European Innovative Biomedicine Institute
Cantabria
Spain
Region: Asia
P.C. Sil (Biography
P.C. Sil

Dr. Sil is currently a senior professor and research coordinator of the “Molecular Medicine” program of Bose Institute, Calcutta, India. He has more than 25 years of research experience in several major areas of chemicals, drugs as well as environmentally exposed nanostructure-induced and oxidative stress mediated organ pathophysiology. Previously, Dr. Sil served as the “Head” of the Division of Molecular Medicine at Bose Institute. Dr. Sil holds a Ph.D. degree in Chemistry from the University of Calcutta and conducted Postdoctoral research at the Cleveland Clinic Foundation, Cleveland, Ohio, USA. Dr. Sil authored more than 130 manuscripts and 8 book chapters; serving as reviewers of more than 170 journals, an Associate Editor of “Toxicology Reports” and an Editorial Board Member of “Heliyon”.

)

Bose Institute
Calcutta
India

Section Editors:

(Type 1 diabetes, diabetes and Pregnancy, insulin analogs, technology and diabetes)
R. Corcoy (Biography
R. Corcoy

Dr. Rosa Corcoy graduated in Medicine in 1982 at Universitat Autònoma de Barcelona, Spain with highest honors. She is currently the Director of the Diabetes Unit at Hospital de la Santa Creu i Sant Pau in Barcelona, Aggregate Professor of the Department of Medicine of the Universitat Autònoma de Barcelona and member of the CIBER-BBN, Zaragoza.

She is a clinical endocrinologist and her research has focused in endocrinological conditions & pregnancy and Type 1 diabetes mellitus. She is author or co-author or more than 100 articles and 40 book chapters. She has received several awards, among them the José Luis Rodriguez Miñón, Sociedad Española de Diabetes in 2010 and the Jorgen Pedersen Award, Diabetic Pregnancy Study Group-EASD in 2012.

She has served in the Board of Associació Catalana de Diabetes, Societat Catalana d’Endocrinologia, Sociedad Española de Diabetes, Grupo Español de Diabetes y Embarazo and Diabetic Pregnancy Study Group-DPSG.

)

Autonomous University
Barcelona
Spain

(Diabetes and cardiovascular risk factors)
A. Misra (Biography
A. Misra

Prof. Anoop Misra is the Chairman, Fortis-CDOC Center of Excellence for Diabetes, Metabolic Diseases, and Endocrinology, New Delhi, India and has been a faculty at the Department of Endocrinology at the Southwestern Medical Center in Dallas, Texas, USA, and All India Institute of Medical Sciences, New Delhi. He has lead consensus guidelines for obesity, the metabolic syndrome, physical activity, and diets for Asian Indians. His current research includes fatty liver and fatty pancreas in relation to insulin resistance and diabetes. He has been awarded highest award for medicine in India Dr BC Roy award (2006) and prestigious Indian National Honor, Padma Shree (2007).

)

Fortis Healthcare flt. Lt. Rajan Dhall Hospital
New Dehli
India

(Diabetic neuropathy, diabetic vascular disease, n-3 polyunsaturated fatty acids)
M.A. Yorek (Biography
M.A. Yorek

Dr. Yorek obtained a doctorate (Ph.D.) in Biochemistry from the University of North Dakota. Currently Dr. Yorek is a Professor in the Division of Endocrinology and Metabolism in the Department of Internal Medicine at the College of Medicine at the University of Iowa. He is also the Associate Chief of Staff at the Iowa City VA Medical Center. His research interest includes vascular and neural complications of obesity and diabetes. He has published more than 140 scientific peer reviewed publications.

)

Vet. Affairs Med. Centre
Iowa City, IA
USA

(Silent myocardial ischemia, erectile dysfunction, patient education, macro vascular complications)
C. Gazzaruso (Biography
C. Gazzaruso

Dr Gazzaruso is Head of the Diabetes and Endocrine-metabolic disease Unit, of the Emergency Unit and of the Center for Applied Clinical Research (Ce.R.C.A.) at Clinical Institute “Beato Matteo”, Vigevano, Italy of the Hospital Group San Donato. He is certified specialist and PhD in Internal Medicine and has a Master on type 2 diabetes. He was specialist and researcher at Maugeri Foundation, Pavia, Italy and consultant in Internal Medicine, Endocrinology and Cardiology at Mondino Foundation, Pavia, Italy. He has the National Scientific Qualification as an Associate Professor of Endocrinology. From 1997 he acts as a contract professor at the University of Pavia. He is authors of more than 90 peer-reviewed articles.

)

University of Pavia
Pavia
Italy

(Type 2 diabetes, endothelial function, atherosclerosis)
M. Tesauro (Biography
M. Tesauro

Manfredi Tesauro obtained his medical degree in from the University Medical School in Palermo, he completed his fellowship in Endocrinology and Metabolic Disease in 2000 at University of Tor Vergata, Rome. From 1998 to 2001 he has been Visiting Fellow, National Institutes of Health, Pulmonary-Critical Care Medicine Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD, United States, to investigate the mechanisms leading to vascular damage in conditions associated with increased atherosclerotic risk. Since 2002, he has served as Clinical Investigator at the Department of Internal Medicine of Tor Vergata University. He is a Director of the Postgraduate School in "Sports Medicine" University of Rome "Tor Vergata" and Scientific Consultant at Italian Medicine Agency (AIFA) for Endocrine and Metabolic Disorders. He has been recipient of several awards and grants, member of many scientific societies and serves as ad hoc reviewer for several peer-reviewed journals. His main research interest over the last decade has focused upon the investigation of the pathophysiological mechanisms of endothelial dysfunction and atherosclerosis in patients with diabetes, obesity and metabolic syndrome. He has authored of more than 100 publications in top-ranked peer-reviewed journals. ( including PNAS, Circulation, Diabetes, Diabetes Care, ATVB, Hypertension, Journal of the American College of Cardiology etc etc)

)

University of Roma Tor Vergata
Rome
Italy


Editorial Board Members:

E.A. Adeghate
UAE University
Al Ain
UAE

D.G. Armstrong (Biography
D.G. Armstrong

Dr. Armstrong is Professor of Surgery (with Tenure) at The University of Arizona and Deputy Director of the Arizona Center for Accelerated Biomedical Innovation (ACABI). Dr. Armstrong holds a Masters of Science in Tissue Repair and Wound Healing from the University of Wales College of Medicine and a PhD from the University of Manchester College of Medicine, where he was appointed Visiting Professor of Medicine. He also co-founded the Southern Arizona Limb Salvage Alliance (SALSA). Armstrong was appointed Deputy Director of the Arizona Center for Accelerated Biomedical Innovation (ACABI) and co-founder of its “augmented human” initiative, which places him at the nexus of the merger of consumer electronics, wearables and medical devices.

)

University of Arizona College of Medicine
Tucson, AZ
USA

V. Bril
University of Toronto
Toronto, ON
Canada

P. Dandona (Biography
P. Dandona

Dr. Dandona is a Distinguished Professor of Medicine and chief of the Division of Endocrinology, Diabetes and Metabolism, at the University at Buffalo, The State University of New York, and the founder of the Diabetes–Endocrinology Center of Western New York in Buffalo. Dr. Dandona is a Rhodes Scholar from India, trained at the University of Oxford and the University of London. Dr. Dandona has published more than 540 papers in peer-reviewed medical journals, and has presented keynote lectures on diabetes and insulin resistance at many national and international conferences

)

Diabetes-Endocrinology Centre of WNY
Buffalo, NY
USA

J. Gerich
University of Rochester
Rochester, NY
USA

H.F. Gu (Biography
H.F. Gu

Dr. Gu’s education background includes VMD (Nanjing, China 1982), MSc in Pathology (Nanjing, China 1988) and PhD in Genetics (Uppsala, Sweden 1994). Currently, he is an Associate Professor in Molecular Genetics, Karolinska Institutet, Stockholm, Sweden. His research interests are mainly focused on molecular medicine and translation medicine in diabetes, obesity and diabetic nephropathy. He has published over 120 peer-reviewed articles in international journals and chapters in three books related with diabetes and diabetic nephropathy.

)

Karolinska University Hospital
Stockholm
Sweden

F. Hu
Harvard School of Public Health
Boston, MA
USA

K. Kamoi (Biography
K. Kamoi

Dr. Kamoi obtained a doctorate (M.D.) on March 1970 in Medicine from theUniversity of Niigata, Japan. Dr. Kamoi also holed an research fellow in september 1977 to May to 1979 from the University of Indiana and Professor of Niigata University in April 2010 to March 2014. Currently, Dr. Kamoi is also an in the Director of Diabetes Mellitus & Disorders of hyothamic pituitary glands in Joetsu General Hospital, Japan. He has published more than 200 scientific publications .Dr. Kamoi was the editor of board members of Current Diabetes Review (2005) of this journal (Current Diabetes Review), published by Bentham Science Publishers.

)

Nagaoka Red Cross Hospital
Niigata
Japan

R.L. Klein (Biography
R.L. Klein

Dr. Klein is Professor of Medicine in the Division of Diabetes, Endocrinology, and Medical Genetics at the Medical University of South Carolina. He is also a Research Health Scientist working in the Research Service of the Department of Veterans Affairs. Dr. Klein holds a doctorate in Pathology from the Bowman Gray School of Medicine at Wake Forest University where he began his research in lipid and lipoprotein metabolism.

)

Medical University of South Carolina
Charleston, SC
USA

K. Mather (Biography
K. Mather

Dr. Mather completed his medical training in Canada, and has pursued a career in clinical research in diabetes since moving to the United States in 2000. He investigates the interplay of hormones and metabolism at the tissue and whole organism levels, and also participates in clinical studies of diabetes and diabetes prevention. He has published over 110 papers, reviews, and chapters.

)

Indiana University
Indianapolis, IN
USA

G. Pacini
CNR Institute
Padua
Italy

P. Raskin
University of Texas
Dallas, TX
USA

G. Seghieri (Biography
G. Seghieri

Giuseppe Seghieri, M.D. graduated cum laude in medicine at the University of Florence, Italy and specialised cum laude in Medical Toxicology (1978), in Gastroenterology (1982), in Clinical Pharmacology (1986), in Internal Medicine (1992) and in Endocrinology (2007) . He was appointed as Assistant Editor of ‘Diabetologia’ (1995-97). Actually he is member of the editorial board of Current Diabetes Reviews. He has been for more than 20 years of Chief of hospital department of internal medicine at the Hospital of Pistoia, Italy and actually is research fellow at the Regional Health Agency of Tuscany, Florence, Italy and professor of Internal Medicine at the University of Florence (Chair of Physiotherapy). He is (co-) author of more than 150 papers mostly dealing with diabetes and its complications, cardiovascular diseases or gender medicine.

)

Spedali Riuniti Via Monte Sabotino
Pistoia
Italy

C.E. de Block (Biography
C.E. de Block

Christophe De Block is Deputy Head of the Department of Endocrinology-Diabetology & Metabolism at Antwerp University Hospital and associate Professor at the University of Antwerp. Prof. De Block’s main clinical and research interests are related to prediction and prevention of type 1 diabetes, autoimmune polyendocrine syndromes, and new treatment options for diabetes, including continuous glucose monitoring, and sensor-augmented pump therapy. Christophe De Block is a member of the European Association for the Study of Diabetes (EASD), the American Diabetes Association (ADA), the Endocrine Society, the Belgian Diabetes Registry, and the Belgian Endocrine Society.

)

University Hospital of Antwerp
Antwerp
Belgium

C.A. Aguilar-Salinas (Biography
C.A. Aguilar-Salinas

Specialist in Internal Medicine and Endocrinology, graduated from the Instituto Nacional de Ciencias Medicas y Nutricion. Doctor of Clinical Investigation. Research follow at the Washington University. School of Medicine. He has published 275 articles in indexed journals. Member of the Mexican National Academy of Medicine. Former president of the Mexican Society of Nutrition and Endocrinology (2009). His work has contributed to describe the epidemiology and genetics of type 2 diabetes and dyslipidemias in Mexicans.

)

National Institute for Medical Science & Nutrition
Mexico City
Mexico

A. Avogaro (Biography
A. Avogaro

Angelo Avogaro is Professor of Endocrinology and Metabolism at the School of Medicine, University of Padova, Italy. He leads the Laboratory of Experimental Diabetology at the Venetian Institute of Molecular Medicine in Padova. Professor Avogaro research focuses on the cellular and molecular mechanisms underlying the development of long-term vascular complications of diabetes and the potential pharmacological prevention and treatment of these conditions.

)

Policlinico Universitario
Padova
Italy

L. Cai (Biography
L. Cai

Dr. Lu Cai received his MD and a Ph.D. in Radiation Biology/Oncology from Jilin University (formally Norman Bethune University of Medical Sciences), Changchun, P.R. China. He also holds the appointment as Visiting Professor at Jilin University and Wenzhou Medical University. Dr. Cai is currently a tenured Professor, with appointments in the departments of Pediatrics, Radiation Oncology and Pharmacology, and Toxicology. Dr. Cai was also appointed as Director of Kosair Children’s Hospital Research Institute, the University of Louisville School of Medicine. He has published more than 210 in the field of diabetes and its complications. Currently, Dr. Cai serves as Associate Editor of Toxicological Science, and was Senior Editor for Journal of Geriatric Cardiology and Journal of Diabetes Research and Clinical Metabolism

)

University of Louisville
Louisville, KY
USA

P. Fernyhough (Biography
P. Fernyhough

Dr. Fernyhough moved to Winnipeg from Manchester, UK, in 2004 and has helped to set up a neuroscience research group at St Boniface Hospital Research Centre with strong links with the Department of Pharmacology & Therapeutics at the University of Manitoba. Dr. Fernyhough’s general research interest is in the cell biology underlying neurodegenerative disorders of the peripheral and central nervous systems with a focus on the impact of diabetes. Current work focuses on muscarinic receptor signaling pathways and regulation of axon outgrowth. Neurobiological processes under study include G-protein coupled receptor signaling and modulation of the cytoskeleton and mitochondrial function.

)

University of Manitoba
Winnipeg, MB
Canada

F. Gomez-Ulla
Gomez-Ulla Eye Institute
Santiago de Compostela
Spain

C. Hampe (Biography
C. Hampe

Dr. Hampe received her PhD at the Weizmann Institute of Science in Israel in 1997. She did her post-doctoral training in Dr. Åke Lernmark’s laboratory at the University of Washington, Seattle and is currently an Associate Professor at the Diabetes Research Institute at the University of Washington. She has 20 years of research experience focusing on autoimmune diseases including Type 1 diabetes and autoimmune neurological disorders. Dr. Hampe has authored over 100 manuscripts. She serves on study sections at the Juvenile Diabetes Research Foundation, the American Diabetes Association and NIH.

)

University of Washington
Seattle, WA
USA

G. Hu
Pennington Biomedical Research Center
Baton Rouge, LA
USA

A.J. Karter (Biography
A.J. Karter

Andrew J. Karter, PhD, has been a Research Scientist at Kaiser Permanente Northern California’s Division of Research for over 20 years, and worked on the design and maintenance of their Diabetes Registry since 1994. He is also the Associate Director for NIDDK’s Health Delivery System’s Center for Diabetes Translational Research. He conducts diabetes epidemiology and health services research, focusing on the areas of hypoglycemia, diabetes care for the elderly, health disparities, language barriers to care, health literacy and provider communication, health information technology, medication adherence, financial barriers and cost-sharing, and pharmacoepidemiology research.

)

Epidemiology & Health Services Research
Oakland, CA
USA

M. Laakso (Biography
M. Laakso

Markku Laakso, MD, PhD, is Professor of Medicine at the Department of Medicine, University of Eastern Finland, Kuopio and Chief Physician of the Department of Medicine, Kuopio University Hospital since 1995. In 2005-2015 he was Academy Professor at the Academy of Finland and at the University of Eastern Finland, Kuopio. His main research interests are genetics of type 2 diabetes, insulin resistance, and cardiovascular disease. He has published 640 original publications and 106 reviews or book chapters. His h-index is 121 and he has > 77 000 citations. He has received several international awards, including Castelli Pedroli Prize (the European Association for the Study of Diabetes) in 2006, Kelly West Award (American Diabetes Association) in 2008, and Claude Bernard Award (the European Association for the Study of Diabetes) in 2013.

)

University of Kuopio
Kuopio
Finland

G. Mazziotti
"Carlo Poma" Hospital
Mantua
Italy

D. B. Panagiotakos (Biography
D. B. Panagiotakos

Demosthenes Panagiotakos is Professor and vice Rector at the Harokopio University in Athens. He is also visiting Distinguished Professor at School of Arts and Sciences, Rutgers, the State University of New Jersey, US, visiting Professor at the School of Medicine, University of Athens and at the Agricultural University of Athens. He has published 3 books, 600+ papers (has >13.500 citations, h-index=55). He is Member of the Scientific Committee of Health, Environment and Emerging Risks of the European Committee, the Scientific Council of the Hellenic Food Authority, the National Council for Nutrition Policy and has served as Board Member of the National Council of Public Health.

)

Harokopio University
Athens
Greece

C. M. Rotella
University of Florence Medical School
Florence
Italy

G. Thomas (Biography
G. Thomas

Neil Thomas is Director of the NIHR Research Design Service for the West Midlands. He is a Reader in Epidemiology, and, Director, Research and Knowledge Transfer at the Institute of Applied Health, University of Birmingham. He has an international research portfolio focussing particularly on populations in Hong Kong and China investigating the aetiology, prognosis, prevention and treatment of those conditions. He has published extensively in the field of cardiometabolic disease with over 250 peer-reviewed papers.

)

The University of Birmingham
Birmingham
UK

F. Angeli
Hospital S.M. della Misericordia
Perugia
Italy

L. Baier (Biography
L. Baier

Dr. Baier serves as Chief of the Diabetes Molecular Genetics Section of the Phoenix Epidemiology and Clinical Research Branch of the National Institute of Diabetes, Digestive and Kidney Diseases (NIDDK), NIH. She has nearly 25 years of experience in studying the genetic basis for type 2 diabetes and obesity in American Indian populations, and has co-authored more than 100 peer reviewed articles on this topic. Dr Baier received her Ph.D. in Cell and Molecular Biology at the University of Michigan, and in addition to her position at the NIH, is an adjunct faculty member at Arizona State University and the University of Arizona College of Medicine in Phoenix Arizona.

)

National Institutes of Health
Phoenix, AZ
USA

C. Catena
University of Udine
Udine
Italy

M. Fukui
Kyoto Prefectural University of Medicine
Kyoto
Japan

A. Green
University of Southern Denmark
Odense
Denmark

K. Hoogenberg (Biography
K. Hoogenberg

Dr. Hoogenberg, was trained as an internist and later on as an endocrinologist in the University Medical Centre Groningen, the Netherlands. At the end of this training he accomplished his PhD thesis on `Renal function abnormalities in diabetes´. He was assigned as associate professor for several years at the University of Groningen and later on moved to the Martini Hospital, a large teaching hospital in the same city. This is his current working address where he executes his speciality in endocrinology and diabetes. His scientific work involves many areas of diabetes and he has published more than 80 peer-reviewed publications and the author of 2 education books.

)

Martini Hospital
Groningen
The Netherlands

T. Kadowaki (Biography
T. Kadowaki

Dr. Kadowaki obtained M.D and Ph.D. in The University of Tokyo. Currently, Dr.Kadowaki is Professor and Chairman, Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo. Professor Kadowaki has been studying the molecular mechanism of insulin resistance and adiponectin action and has over six hundred scientific publications. Professor Kadowaki is also on the Editorial Board of Cell Metabolism and Molecular Metabolism.

)

University of Tokyo
Tokyo
Japan

A. King (Biography
A. King

Allen Bennett King, MD, FACP, FACE, CDE, received his degrees and training at the University of California, Berkeley; Creighton University Medical School; the University of Colorado; and Stanford University. He has authored more than150 papers, book chapters and books in medical science and speaks nationally and internationally on new advances in diabetes. He is an advisor and reviewer for several medical journals. He is an Associate Clinical Professor at the University of California, San Francisco, Natividad Medical Center, and medical director of the Diabetes Care Center in Salinas, California. His current major interest is in insulin dosing.

)

Diabetic Care Research Centre
Salinas, CA
USA

I. Laher (Biography
I. Laher

Dr. ismail Laher is a Professor of Pharmacology and Therapeutics at the University of Pharmacology. He holds a degree in pharmacology from the University of London and graduate training in Canada and post-graduate training at the University of Vermont. Dr. Laher’s research interests are in vascular regulation (particularly of small arteries) in health and disease and the effects of exercise in improving endothelial function (e.g. in diabetes). More recent work focusses on the vascular function in rodent models of obstructive sleep apnea (especially in conjunction with underlying complications of diabetes / obesity).

)

The University of British Columbia
BC
Canada

P.J. Neuvonen
University of Helsinki
Helsinki
Finland

F. Pouwer
Tilburg University
Tilburg
The Netherlands

P. Ruggenenti (Biography
P. Ruggenenti

Dr. Piero Ruggenenti is an Assistant Professor in the Unit of Nephrology and Dialysis of the ASST Papa Giovanni XXIII, Bergamo, Italy and is Head of the Department of Renal Medicine at Mario Negri Institute for Pharmacological Research in Bergamo. Since 1984 he has been member of Organizing Secretariat of the International Registry of HUS. He is member of the Editorial Board of several journals. He is author of more than 330 scientific articles, focused on renal disease progression, renal vascular biology in uremia, the role of protein trafficking in renal disease progression and the understanding of the pathophysiology of hemolytic uremic syndrome.

)

Mario Negri Institute
Bergamo
Italy

A.I. Vinik (Biography
A.I. Vinik

Dr. Vinik is an international leader in basic and clinical neuropathy and neuroendocrine tumors, and isolated INGAP in clinical trials for “Curing” diabetes. He has authored ten books, 124 book chapters, and published more than 500 papers in highly reputable journals. Dr. Vinik received the Virginia Outstanding Scientist Award, was elected a Health Care Hero, received lifetime recognition for contributions to Neuropathy and a distinction in endocrinology. He has served NIH and ADA grant committees and funded by NIH, NIAA, ADA and industry. He holds patents for INGAP and copyrights for the Norfolk Quality of Life DN and NET tools.

)

Strelitz Diabetes Research Institute
Norfolk, VA
USA


Advertisement

Related Journals




Related eBooks



Webmaster Contact: info@benthamscience.org Copyright © 2017 Bentham Science